All Publications | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 1 result.

- Speech
Phase 2 randomised trial of oral C5A receptor antagonist CCX168 in ANCA-associated renal vasculitis
Jayne, D. R. W. Bruchfeld, A. Schaier, M. Ciechanowski, K. Harper, L. Jadoul, Michel[UCL] Segelmark, M. Selga, D. Szombati, I. Venning, M. Hamilton, P. Hugo, C. Van Daele, P. L. A. Viklicky, O. Potarca, A. Schall, T. J. Bekker, P. (2014) 51ST ERA-EDTA CONGRESS — Amsterdam